FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to medicine, particularly to traumatology, orthopaedis, maxillofacial surgery, dentistry, neurosurgery, namely to osteoplastic formulation of biocomposites for treating human bone diseases and injures, and can be used as a material fully degradable in the body and replaceable by new bone tissue, for bone cell regeneration, as a biological filler for bone tissue defects, as an osteoconductive and osteoinductive biological frame for bone tissue regeneration. The hardened biocomposite for bone defect replacement on the basis of calcium phosphate contains magnesium phosphate, calcium hydrophosphate, amino acid; calcium phosphate is biological hydroxyapatite in the following proportions, wt %: hydroxyapatite - 45-47, magnesium phosphate - 32-34, calcium hydrophosphate - 16-19, amino acid - 1-5, as a binding agent - casein.
EFFECT: implementing the expansion of the biocomposites for bone defect replacement and endoprosthesis fixation.
1 cl
| Title | Year | Author | Number |
|---|---|---|---|
| OSTEOPLASTIC BIORESORBABLE MATERIAL FOR BONE DEFECT REPLACEMENT AND METHOD FOR PREPARING IT | 2012 |
|
RU2504405C1 |
| BIODEGRADABLE MATERIAL FOR BONE TISSUE REPLACEMENT | 2014 |
|
RU2552943C1 |
| METHOD OF BONE TISSUE SUBSTITUTION | 2014 |
|
RU2553368C1 |
| BIOACTIVE COMPOSITE MATERIAL FOR BONE DEFECT REPLACEMENT AND METHOD FOR ITS MANUFACTURE | 2016 |
|
RU2617050C1 |
| BIOCOMPATIBLE BONE-SUBSTITUTING MATERIAL AND METHOD OF OBTAINING THEREOF | 2012 |
|
RU2494721C1 |
| POROUS MICROSPHERES OF CALCIUM AND MAGNESIUM BIOPHOSPHATE WITH ADJUSTED PARTICLE SIZE FOR BONE TISSUE REGENERATION | 2012 |
|
RU2497548C1 |
| CEMENT FOR REPLACING OSSEOUS TISSUE | 2003 |
|
RU2236216C1 |
| BIO-COMPOSITION MATERIAL APPLIED FOR OSTEOPLASTY | 2006 |
|
RU2325170C1 |
| METHOD OF PRODUCTION OF PROTEIN-MINERAL COMPOSITION CONTAINING RECOMBINANT PROTEIN Collbd-BMP-2 | 2012 |
|
RU2492237C1 |
| SCAFFOLD FOR BONE DEFECT REPLACEMENT | 2020 |
|
RU2768571C1 |
